TABLE 1.
Patient demographics
| Demographic | LDL Analysis Population | DEFINE Anacetrapib Treatment Group |
| (N = 280) | (N = 811) | |
| Age (years) [mean (SD)] | 62.5 ± 8.8 | 62.5 ± 8.7 |
| <65 | 155 (55.4) | 455 (56.1) |
| ≥65 | 125 (44.6) | 356 (43.9) |
| Gender, N (%) | ||
| Female | 61 (21.8) | 182 (22.4) |
| Male | 219 (78.2) | 629 (77.6) |
| Race, N (%) | ||
| White | 244 (87.1) | 686 (84.6) |
| Asian | 15 (5.4) | 54 (6.7) |
| Other | 13 (4.6) | 49 (6.0) |
| Black or African American | 8 (2.9) | 22 (2.7) |
| Diabetic, N (%) | ||
| Yes | 157 (56.1) | 430 (53.0) |
| No | 123 (43.9) | 381 (47.0) |
| Baseline LDL-C [mean (SD) mg/dl] | 74.1 (21.6) | 81.4 (21.2) |
| Baseline HDL-C [mean (SD) mg/dl] | 40.5 (8.3) | 40.5 (9.3) |
| Baseline TG [median (SD) mg/dl] | 123.5 (57.0) | 127.0 (66.5) |
| Baseline Total-C [mean (SD) mg/dl] | 141.4(25.3) | 150.4 (25.9) |